274 related articles for article (PubMed ID: 22249269)
1. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
2. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
3. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
4. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
Hyun KH; Yoon CH; Kim RK; Lim EJ; An S; Park MJ; Hyun JW; Suh Y; Kim MJ; Lee SJ
Toxicol Appl Pharmacol; 2011 Jul; 254(1):32-40. PubMed ID: 21514314
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
6. JNK is required for maintaining the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.
Liu Y; Zhang X; Wang J; Yang J; Tan WF
Acta Pharmacol Sin; 2015 Sep; 36(9):1099-106. PubMed ID: 26235742
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
9. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
10. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
11. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
12. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.
Liu Q; Bai W; Huang F; Tang J; Lin X
Int J Biochem Cell Biol; 2019 Oct; 115():105571. PubMed ID: 31352088
[TBL] [Abstract][Full Text] [Related]
14. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis.
Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Kim BK; Kim HM; Chung KS; Kim DM; Park SK; Song A; Won KJ; Lee K; Oh YK; Lee K; Song KB; Simon JA; Han G; Won M
Carcinogenesis; 2011 Mar; 32(3):254-61. PubMed ID: 21084431
[TBL] [Abstract][Full Text] [Related]
18. Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells.
Mielke K
Mol Cell Neurosci; 2008 Jul; 38(3):301-11. PubMed ID: 18513991
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
20. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]